Advertisement

BMC Infectious Diseases

, 14:P9 | Cite as

Bacteriological diagnosis of β-hemolytic streptococci of the upper respiratory tract

  • Alina Borcan
  • Olga Dorobăț
  • Ioana Bădicuț
  • Daniela Tălăpan
  • Mariana Radut
  • Mona Popoiu
  • Anca Munteanu
  • Alexandru Rafila
Open Access
Poster presentation
  • 245 Downloads

Keywords

Erythromycin Clindamycin Bacitracin Latex Agglutination Preferable Alternative 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Background

Beta-hemolytic streptococci are major human pathogens associated with local or systemic invasion and post-streptococcal immune disorders. We performed a comparison between bacitracin and latex agglutination test for the identification of beta-hemolytic streptococci. We assessed resistance patterns to erythromycin/clindamycin.

Methods

Between January 1 2014 – July 15 2014, 5038 throat swabs were sampled from patients hospitalized in INBI Matei Balş according to standard methods. All beta-hemolytic streptococci suspected colonies were tested with bacitracin (0.04%) disks and we used the latex agglutination kit Omega Latex Diagnostic Avipath Strep. Erythromycin resistance testing was performed by disc 2μg Oxoid and clindamycin 2μg Oxoid on the blood M-H medium.

Results

There were 460 isolates of beta-hemolytic streptococci, bacitracin test was positive for 373 (92.75%). From 87 negative bacitracin test left streptococci, with latex agglutination test, 18 (20.68%) were identified as Streptococcus pyogenes (group A) and 69 (79.32%) were group C, G, B, F. Streptococcus pyogenes had 8.95% resistance to erythromycin, group C streptococci had 2.12%, and group G 45.45. From strains with resistance to erythromycin 75.6% were with inducible resistance to clindamycin and 17.07% had a constitutive one.

Conclusion

Latex agglutination is a preferable alternative to bacitracin testing, providing a definite grouping result.

Resistance of Streptococcus pyogenes to erythromycin was 8.95% compared with group G which had a resistance of 45.45%.

Copyright information

© Borcan et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Alina Borcan
    • 1
    • 2
  • Olga Dorobăț
    • 2
  • Ioana Bădicuț
    • 1
    • 2
  • Daniela Tălăpan
    • 1
    • 2
  • Mariana Radut
    • 2
  • Mona Popoiu
    • 2
  • Anca Munteanu
    • 3
  • Alexandru Rafila
    • 1
    • 2
  1. 1.Carol Davila University of Medicine and PharmacyBucharestRomania
  2. 2.National Institute for Infectious Diseases "Prof. Dr. Matei Balş"BucharestRomania
  3. 3.National Institute of Public HealthBucharestRomania

Personalised recommendations